Ranolazine dihydrochloride
| CAS No. | 95635-56-6 | Cat. No. | BCP22680 |
| Name | Ranolazine dihydrochloride | ||
| Synonyms | Ranolazine 2HCl;RS 43285; RS-43285; RS43285; CVT-303; CVT 303; CVT303; | ||
| Formula | C24H35Cl2N3O4 | M. Wt | 500.46 |
| Description | Ranolazine is an anti-ischemic compound, which inhibits late sodium current that results in a reduction of Na+ dependent Ca2+ overload. Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine. This is due to the fact that more oxygen is required to phosphorylate the same amount of ATP during fatty acid oxidation than carbohydrate oxidation. These studies indicate that Ranolazine also inhibits oxygen consumption and ketogenesis by fatty acids in liver cells. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | Calcium Channel Sodium Channel | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.